BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18394551)

  • 1. RanBP2: a tumor suppressor with a new twist on TopoII, SUMO, and centromeres.
    Navarro MS; Bachant J
    Cancer Cell; 2008 Apr; 13(4):293-5. PubMed ID: 18394551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.
    Dawlaty MM; Malureanu L; Jeganathan KB; Kao E; Sustmann C; Tahk S; Shuai K; Grosschedl R; van Deursen JM
    Cell; 2008 Apr; 133(1):103-15. PubMed ID: 18394993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
    Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
    Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RanBP2 resolves sister centromeres.
    Grisendi S
    Nat Cell Biol; 2008 May; 10(5):512. PubMed ID: 18454131
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.
    Horio Y; Osada H; Shimizu J; Ogawa S; Hida T; Sekido Y
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):237-43. PubMed ID: 19809814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Top2 SUMO conjugation in yeast cell lysates.
    Baldwin M; Bachant J
    Methods Mol Biol; 2009; 582():209-19. PubMed ID: 19763952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.
    Lee MT; Bachant J
    DNA Repair (Amst); 2009 Apr; 8(4):557-68. PubMed ID: 19230795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell biology. SUMO wrestles its way to prominence in the cell.
    Marx J
    Science; 2005 Feb; 307(5711):836-9. PubMed ID: 15705823
    [No Abstract]   [Full Text] [Related]  

  • 10. Aurora B SUMOylation Is Restricted to Centromeres in Early Mitosis and Requires RANBP2.
    Di Cesare E; Moroni S; Bartoli J; Damizia M; Giubettini M; Koerner C; Krenn V; Musacchio A; Lavia P
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-2/3 regulates topoisomerase II in mitosis.
    Azuma Y; Arnaoutov A; Dasso M
    J Cell Biol; 2003 Nov; 163(3):477-87. PubMed ID: 14597774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RanGAP1*SUMO1 is phosphorylated at the onset of mitosis and remains associated with RanBP2 upon NPC disassembly.
    Swaminathan S; Kiendl F; Körner R; Lupetti R; Hengst L; Melchior F
    J Cell Biol; 2004 Mar; 164(7):965-71. PubMed ID: 15037602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.
    Pichler A; Knipscheer P; Saitoh H; Sixma TK; Melchior F
    Nat Struct Mol Biol; 2004 Oct; 11(10):984-91. PubMed ID: 15378033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function.
    Gilistro E; de Turris V; Damizia M; Verrico A; Moroni S; De Santis R; Rosa A; Lavia P
    J Cell Sci; 2017 Aug; 130(15):2564-2578. PubMed ID: 28600321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes.
    Azuma Y; Arnaoutov A; Anan T; Dasso M
    EMBO J; 2005 Jun; 24(12):2172-82. PubMed ID: 15933717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase II: untangling its contribution at the centromere.
    Porter AC; Farr CJ
    Chromosome Res; 2004; 12(6):569-83. PubMed ID: 15289664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of the C-terminal domain of DNA topoisomerase IIα regulates the centromeric localization of Claspin.
    Ryu H; Yoshida MM; Sridharan V; Kumagai A; Dunphy WG; Dasso M; Azuma Y
    Cell Cycle; 2015; 14(17):2777-84. PubMed ID: 26131587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIASy-dependent SUMOylation regulates DNA topoisomerase IIalpha activity.
    Ryu H; Furuta M; Kirkpatrick D; Gygi SP; Azuma Y
    J Cell Biol; 2010 Nov; 191(4):783-94. PubMed ID: 21079245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-interacting motifs (SIMs) in Polo-like kinase 1-interacting checkpoint helicase (PICH) ensure proper chromosome segregation during mitosis.
    Sridharan V; Azuma Y
    Cell Cycle; 2016 Aug; 15(16):2135-2144. PubMed ID: 27230136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.